Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.
SHANGHAI, Jan. 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed in a clinical trial in the U.S. of its independently...
PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader
BURLINGTON, Mass., Jan. 22, 2026 /PRNewswire/ -- PAQ Therapeutics, a clinical-stage oncology company developing novel targeted protein degradation therapies for KRAS-driven cancers, today announced the closing of a Series B extension, bringing the...
Datasea Pre-Announces Fiscal Year 2026 Second Quarter Results
Gross Profit Increased 278% Year-over-Year with Significant Improvement in Gross Margin BEIJING, Jan. 21, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada-based technology company specializing in acoustic...
Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System
Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right ventricle function YOKNEAM, Israel, Jan. 21, 2026 /PRNewswire/ -- Trisol Medical, a...
Shopware Announces New "B2B Ecommerce Compass 2026" Whitepaper and "B2B Future Forum" Webinar Series to Guide Merchants Into the Future
SCHÖPPINGEN, Germany, Jan. 20, 2026 /PRNewswire/ -- Shopware, a leading global ecommerce platform provider, is reinforcing its role as a strategic thought leader in B2B commerce with the release of its new whitepaper "B2B Ecommerce Compass 2026,"...
Bitmine Immersion Technologies (BMNR) Announces $200 Million Investment in Beast Industries
Bitmine will hold its Annual Stockholder Meeting at the Wynn Las Vegas on January 15, 2026 Bitmine is supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG,...
BankPro Announces Partnership with McLaren Endurance Racing in its World Endurance Championship Entry
NASSAU, Bahamas, Jan. 14, 2026 /PRNewswire/ -- BankPro is proud to announce its partnership with Racing's endurance ambitions, partnering with the McLaren United Autosports WEC Hyper Team, McLaren Racing's official entry in the FIA World Endurance...
Future FinTech Group Inc. Announces Reverse Stock Split with Marketplace Effective Date on January 20, 2026
NEW YORK, Jan. 14, 2026 /PRNewswire/ -- Future FinTech Group Inc. (Nasdaq: FTFT) (the "Company") today announced that it will implement a reverse stock split of its common stock at a ratio of four (4) to one (1). The Company's common stock will...
Ractigen Therapeutics Announces First Patient Dosed in Phase II Clinical Trial of RAG-17 for SOD1-ALS
NANTONG, China, Jan. 13, 2026 /PRNewswire/ -- Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral...
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research
FREMONT, Calif., Jan. 13, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ AD...